Brito Julio, Siques Patricia, Pena Eduardo
Institute of Health Studies, Universidad Arturo Prat, Iquique, Chile.
Institute DECIPHER, German-Chilean Institute for Research on Pulmonary Hypoxia and Its Health Sequelae, Hamburg, Germany.
Pulm Circ. 2020 Oct 13;10(1 Suppl):5-12. doi: 10.1177/2045894020934625. eCollection 2020 Jul-Sep.
In some subjects, high-altitude hypobaric hypoxia leads to high-altitude pulmonary hypertension. The threshold for the diagnosis of high-altitude pulmonary hypertension is a mean pulmonary artery pressure of 30 mmHg, even though for general pulmonary hypertension is ≥25 mmHg. High-altitude pulmonary hypertension has been associated with high hematocrit findings (chronic mountain sickness), and although these are two separate entities, they have a synergistic effect that should be considered. In recent years, a new condition associated with high altitude was described in South America named long-term chronic intermittent hypoxia and has appeared in individuals who commute to work at high altitude but live and rest at sea level. In this review, we discuss the initial epidemiological pattern from the early studies done in Chile, the clinical presentation and possible molecular mechanism and a discussion of the potential management of this condition.
在一些受试者中,高原低压缺氧会导致高原肺动脉高压。高原肺动脉高压的诊断阈值是平均肺动脉压30 mmHg,而一般肺动脉高压的诊断阈值是≥25 mmHg。高原肺动脉高压与高血细胞比容表现(慢性高原病)有关,尽管它们是两个不同的实体,但具有协同作用,应予以考虑。近年来,南美洲描述了一种与高原相关的新病症,称为长期慢性间歇性缺氧,出现在往返于高原工作但在海平面生活和休息的个体中。在本综述中,我们讨论了智利早期研究的初步流行病学模式、临床表现、可能的分子机制以及对该病症潜在治疗方法的探讨。